Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Contaminated Zantac Lawsuits Could be Centralized in Single Federal Court

Plaintiffs pursuing lawsuits over contaminated Zantac have requested that their claims be centralized before a single judge in one federal jurisdiction. 15 Zantac Lawsuits Pending in Federal Courts Nationwide According to a Motion for Transfer filed with the U.S. Judicial … Continue reading

Pennsylvania’s First IVC Filter Lawsuit Plaintiff Awarded $34 Million

Pennsylvania’s first product liability trial involving inferior vena cava (IVC) filters concluded late last month, with a Philadelphia jury awarding nearly $34 million to the plaintiff. What this Case Was About Tracy Reed-Brown received Rex Medical LP’s Option IVC filter in … Continue reading

Catskills Boys Camp Named in New Child Victims Act Lawsuit

A man who says he was molested by a rabbi while attending a summer camp for Jewish boys in the Catskills decades ago is pursuing a clergy sexual abuse lawsuit under New York’s recently passed Child Victims Act. Plaintiff Attended … Continue reading

Two Florida Women Seek $5 Million for Recalled Biocell Breast Implants

Allergan Inc. is facing yet another lawsuit over recalled Biocell textured breast implants. This latest complaint was filed on October 22nd in the U.S. District Court, Middle District of Florida, and seeks to force Allegan to cover the cost of … Continue reading

FDA Criticized for Downplaying Zantac Cancer Risk

The online pharmacy that first detected a potentially cancer-causing chemical in branded and generic versions of Zantac had sharp words for the U.S. Food & Drug Administration (FDA) late last week, after the agency said its own testing suggested ranitidine … Continue reading

Latest Sex Trafficking Lawsuits Target Hotels in Georgia, New York City

Sex trafficking lawsuits continue to mount in courts around the United States, with the most recent filings targeting hotels in Georgia and New York City. New York Hotels Allegedly Enabled Abuse of 10-year-Old A complaint filed on Tuesday in Brooklyn … Continue reading

FDA Announces Yet Another Class I Recall for Ethicon Surgical Staplers

The U.S. Food & Drug Administration (FDA) has announced yet another Class I recall for surgical staplers marketed by Ethicon, Inc. Ethicon Surgical Stapler Recall Followed Patient Death This latest action involves more than 8,200 Echelon Flex Endopath staplers that … Continue reading

EPA Seeking Public Comment on Paraquat Health & Environmental Dangers

The U.S. Environmental Protection Agency (EPA) is seeking public comments regarding the health and environmental dangers associated with paraquat, a widely used pesticide that has been linked to Parkinson’s disease. Like other pesticides, paraquat must undergo EPA review every 15 … Continue reading

Johnson & Johnson Denied Recusal Bid in $8 Billion Risperdal Verdict

A state court judge in Philadelphia, Pennsylvania has refused to recuse himself from a key Risperdal lawsuit, just weeks after Johnson & Johnson and it’s Janssen Pharmaceuticals unit were ordered to pay $8 billion in punitive damages to a Maryland man … Continue reading

Monsanto Roundup Lawsuits Surge, As Bayer Reports Over 43,000 Cancer Filings

Monsanto Roundup lawsuits have surged in recent months, with Bayer AG reporting that 43,700 cases alleging glyphosate caused cancer are now pending in courts around the United States. That means the already-massive litigation has doubled since July, when the number … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content